| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/16/2007 | WO2007092403A1 N-phenylbenzotriazolyl c-kit inhibitors |
| 08/16/2007 | WO2007092178A1 Hydrate forms of amg706 |
| 08/16/2007 | WO2007092157A1 7-(1h-imidazol-4-yl) methyl) -5,6,7,8-tetrahydroquinoline |
| 08/16/2007 | WO2007091736A1 Novel coumarin derivative having antitumor activity |
| 08/16/2007 | WO2007091703A1 N-hydroxyacrylamide compounds |
| 08/16/2007 | WO2007091683A1 Bissquarylium compound |
| 08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
| 08/16/2007 | WO2007091176A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives |
| 08/16/2007 | WO2007091046A1 Chemical compounds |
| 08/16/2007 | WO2007090859A1 Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{ [ (r)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl] } -5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders |
| 08/16/2007 | WO2007090841A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 08/16/2007 | WO2007090826A1 Piperidine derivatives as cxcr3 receptor antagonists |
| 08/16/2007 | WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/16/2007 | WO2007090461A1 Use of metal complex compounds as oxidation catalysts |
| 08/16/2007 | WO2007090343A1 LABEL-FREE OPTICAL SENSING AND CHARACTERIZATION OF BIOMOLECULES BY d8 OR d10 METAL COMPLEXES |
| 08/16/2007 | WO2007070826B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 08/16/2007 | WO2007065261B1 Plasminogen activator inhibitor-1 inhibitors |
| 08/16/2007 | WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
| 08/16/2007 | US20070191614 Process for producing nitrogenous 5-membered cyclic compound |
| 08/16/2007 | US20070191516 Process for the synthesis of amine ethers |
| 08/16/2007 | US20070191457 Compounds having activity at 5ht2c receptor and uses thereof |
| 08/16/2007 | US20070191447 Novel heterocyclic compound |
| 08/16/2007 | US20070191444 Benzimidazolyl derivatives |
| 08/16/2007 | US20070191429 Ppar activators |
| 08/16/2007 | US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 08/16/2007 | US20070191424 such as (2R)-2-{(1S)-6,7-dimethoxy-1-[2-(4-trifluoromethyl-phenyl)-ethyl]-3,4-dihydro-1H-isoquinolin-2-yl}-N-methyl-2-phenyl-acetamide, used as orexin receptor antagonists, for preventing or treating sleep disorders |
| 08/16/2007 | US20070191423 Isoquinoline derivatives |
| 08/16/2007 | US20070191420 Kinase inhibitors |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191414 Novel isoamido-substituted hydroxy-6-phenylphenanthridines |
| 08/16/2007 | US20070191413 Novel heterocycle-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
| 08/16/2007 | US20070191401 Transplant rejection, autoimmune disease, autoimmune disease |
| 08/16/2007 | US20070191388 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, antiarthritic, anticarcinogenic, antitumor, antidiabetic; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma |
| 08/16/2007 | US20070191383 Mtp inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles |
| 08/16/2007 | US20070191372 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy |
| 08/16/2007 | US20070191364 Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
| 08/16/2007 | US20070191358 Novel piperidine derivative for the treatment of depression |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191345 3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 08/16/2007 | US20070191344 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
| 08/16/2007 | US20070191341 N-Substituted Benzene Sulfonamides |
| 08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
| 08/16/2007 | US20070190355 Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
| 08/16/2007 | US20070189987 Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof |
| 08/16/2007 | US20070189970 Contrast medium for thrombus formation |
| 08/16/2007 | US20070189865 Amino cyclopropane carboxamide derivatives as bradykinin antagonists |
| 08/16/2007 | CA2651987A1 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 08/16/2007 | CA2641769A1 Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(r)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders |
| 08/16/2007 | CA2641609A1 11-beta hsd1 inhibitors |
| 08/16/2007 | CA2641579A1 N-hydroxyacrylamide compounds |
| 08/16/2007 | CA2641307A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | CA2640665A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives |
| 08/16/2007 | CA2640652A1 Novel coumarin derivative having antitumor activity |
| 08/16/2007 | CA2637771A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/16/2007 | CA2637768A1 Benzamide and heteroarene derivatives |
| 08/16/2007 | CA2637225A1 Compounds and compositions as protein kinase inhibitors |
| 08/16/2007 | CA2637204A1 Substituted quinolones iii |
| 08/16/2007 | CA2635137A1 Piperidine derivatives as cxcr3 receptor antagonists |
| 08/16/2007 | CA2627900A1 Compounds and compositions as lxr modulators |
| 08/15/2007 | EP1818331A1 Process for the preparation of 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole substantially free of sulfone impurity |
| 08/15/2007 | EP1818330A1 Substituted proline amides, preparation and use as medicaments thereof |
| 08/15/2007 | EP1818329A1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2methyl-1,4homopiperazine hydrochloride dihydrate |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817834A1 Method and installation means for installing an electrical machine |
| 08/15/2007 | EP1817312A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/15/2007 | EP1817309A1 Acetamide compounds as fungicides |
| 08/15/2007 | EP1817306A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 08/15/2007 | EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases |
| 08/15/2007 | EP1817304A2 Metallic chromonic compounds |
| 08/15/2007 | EP1817303A2 Substituted pyridines with activity on syk kinase |
| 08/15/2007 | EP1817302A2 Piperidinyl piperidine tachykinin receptor antagonists |
| 08/15/2007 | EP1817301A1 Potentiators of glutamate receptors |
| 08/15/2007 | EP1817300A1 Potentiators of glutamate receptors |
| 08/15/2007 | EP1817295A1 Triazole compounds that modulate hsp90 activity |
| 08/15/2007 | EP1817294A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 08/15/2007 | EP1817292A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 08/15/2007 | EP1817288A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 08/15/2007 | EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 08/15/2007 | EP1817284A2 Cycloalkyl piperidine tachykinin receptor antagonists |
| 08/15/2007 | EP1817283A1 2-substituted indoles, their precursors and novel processes for the preparation thereof |
| 08/15/2007 | EP1817030A2 Inducible nitric oxide synthase dimerization inhibitors |
| 08/15/2007 | EP1646620B1 Substituted piperidines as histamine h3 receptor ligands |
| 08/15/2007 | EP1597235B1 Non-nucleoside reverse transcriptase inhibitors |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1448531B1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/15/2007 | EP1440069B1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | EP1259242B1 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/15/2007 | EP1222922B1 Method for stabilizing benzimidazole compounds |
| 08/15/2007 | CN1331863C Imide analog compounds and its preparation method |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018783A Quinoxaline inhibitors of the HEDGEHOG signalling pathway |
| 08/15/2007 | CN101018782A Hydantoin compound for the treatment of inflammatory disorders |
| 08/15/2007 | CN101018781A Bicyclic N-anilide spirolactam CGRP receptor antagonists |